Form 4 for DMAC DiaMedica Therapeutics Inc.
Accepted 2023-06-26 00:00:00 ET · period of report 2023-06-23 · accession 0001235802-23-000069 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-26 | 2023-06-23 | DMAC | Wambeke David J. | Chief Business Off | P - Purchase | $3.91 | +38.4K | 507.1K | +8% | +$150.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Voting Common Shares, no par value per share | 2023-06-23 | P | A | 38,364 | $3.91 | 507,114 | D | — | — |